SSA
YCBD icon

Schonfeld Strategic Advisors’s cbdMD YCBD Stock Holding History

Schonfeld Strategic Advisors’s Portfolio YCBD Stock Details YCBD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-54
Closed -$20K – 3063
2022
Q1 		$20K Buy
+54
New +$18.2K ﹤0.01% 2398

Other funds holding YCBD

Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
MC
Merlin Capital Newport, Rhode Island $33.5M AUM 36.34% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AI
AdvisorShares Investments Bethesda, Maryland $549M AUM 32.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
PCM
Penserra Capital Management Orinda, California $8.52B AUM 37.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
CIM
Cambria Investment Management Manhattan Beach, California $1.79B AUM 28.1% 1-Year Est. Return

Schonfeld Strategic Advisors's YCBD Position: Q2 2022 in Review

Schonfeld Strategic Advisors sold out of cbdMD (YCBD) in Q2 2022, closing a stake of 54 shares — an estimated $20K sold.

Schonfeld Strategic Advisors first reported a position in YCBD in Q1 2022 and held it in 1 quarter. The position peaked at $20K in Q1 2022. 51 funds tracked by Wall St. Rank hold YCBD as of Q2 2022.

  • Schonfeld Strategic Advisors reported no remaining cbdMD position as of Q2 2022 after selling out during the quarter.
  • Schonfeld Strategic Advisors sold 54 cbdMD shares in Q2 2022, an estimated $20K.
  • Schonfeld Strategic Advisors first reported a position in cbdMD in Q1 2022 and held it in 1 quarter.
  • Schonfeld Strategic Advisors's cbdMD position peaked at $20K in Q1 2022.
  • 51 funds tracked by Wall St. Rank held cbdMD as of Q2 2022.

Based on Schonfeld Strategic Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.